Concepedia

Angela Campanella

AC

Statistics

Publications

23

Citations

2.6K

H-Index

18

Active since

2003

Affiliations

Fondazione IRCCS Istituto Neurologico Carlo Besta(Current)

Alexion Pharmaceuticals (United States)

University of Campania "Luigi Vanvitelli"

National Hospital Organization Hanamaki Hospital

University of North Carolina at Chapel Hill

Angela Campanella is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Publications per year

2003–2023

23

Publications

23

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

, , +4

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

Gabriella Marcon, Alain Mallet, Mauro Tettamanti et al. · The Lancet Neurology · 2014 · 204 citations

, , +4

Myasthenia Gravis (MG): Epidemiological Data and Prognostic Factors

Renato Mantegazza, Fulvio Baggi, Carlo Antozzi et al. · Annals of the New York Academy of Sciences · 2003 · 160 citations

, , +6

Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

K. Hewett, Donald B. Sanders, Richard Grove et al. · Neurology · 2018 · 128 citations · Full text

, , +14

1–5 of 23